Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in relapsed/recurrent head and neck squamous cell carcinoma
2009-014396-43Phase 2Completed
- Sponsor
- Hannover Medical School
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in head and neck squamous cell carcinoma (HNSCC), sponsored by Hannover Medical School. Primary endpoint: progression-free rate at day 84. Started Jan 2010; status: completed.
02
Drugs
temsirolimus
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2009-014396-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014396-43.